Previous Chapter Chapter 14: Biomedical Research Policy and Innovation (1940s–Present) Next Chapter

Michael McGeary & Robert Cook-Deegan

In: Guide to U.S. Health and Health Care Policy

Chapter 14: Biomedical Research Policy and Innovation (1940s–Present)

  • Citations
  • Add to My List
  • Text Size

Biomedical Research Policy and Innovation (1940s–Present)
Biomedical research policy and innovation (1940s–present)
MichaelMcGeary and RobertCook-Deegan

Since the end of World War II national biomedical research policy in the United States has emphasized public support of a large and broad program of primarily basic research aimed at advancing knowledge of biological processes, on the premise that such knowledge would lead to better ways to cure or prevent diseases that afflict the American people. Public funding, primarily National Institutes of Health (NIH) research grants to biomedical scientists in academia, has always included some clinical research, drug development, and support for clinical trials, but the main responsibility for innovation, defined as turning new knowledge into practical uses, has been left to the private sector. There have been exceptions, usually driven ...

Looks like you do not have access to this content.


Don’t know how to login?

Click here for free trial login.

Back to Top

Copy and paste the following HTML into your website